(Q82870715)

English

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

scientific article published on 17 October 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

type 2 diabetes

1 reference

based on heuristic

inferred from title

0 references

author name string

Yoshimasa Aso

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Noriyuki Ozeki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tomoko Terasawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Rika Naruse

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kenji Hara

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mariko Suetsugu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kohzo Takebayashi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mitsuei Shibazaki

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kohsuke Haruki

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kimio Morita

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Toshihiko Inukai

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

17 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

159

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

25-31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

The role of incretins in glucose homeostasis and diabetes treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Biology of incretins: GLP-1 and GIP

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

DPP-4 inhibitors: what may be the clinical differentiators?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Molecular characterization of dipeptidyl peptidase activity in serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

On the origin of serum CD26 and its altered concentration in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Obesity, diabetes mellitus, and liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.09.005

7 January 2021

Identifiers

10.1016/J.TRSL.2011.09.005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22153807%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82870715&oldid=2236072831"